acut
bronchiol
common
epidem
viral
infect
infant
respons
numer
consult
pediatr
emerg
ward
autumn
winter
season
first
two
year
life
relaps
frequent
recurr
wheez
diagnos
third
episod
wheez
requir
adapt
therapeut
causal
virus
acut
bronchiol
mainli
respiratori
syncyti
viru
rsv
rhinovirus
metapneumovirus
parainfluenza
influenza
virus
also
receptor
advanc
glycat
rage
member
immunoglobulin
superfamili
constitut
express
mani
tissu
rage
membran
receptor
mrage
recogn
molecular
pattern
damp
studi
ligand
advanc
glycat
age
high
mobil
group
box
protein
protein
famili
bind
one
ligand
activ
transcript
nuclear
factor
lead
inflammatori
process
rage
level
lung
tissu
particularli
high
suggest
import
role
rage
pulmonari
physiolog
rage
found
alveolar
bronchial
epitheli
cell
mainli
locat
basolater
membran
alveolar
type
cell
rage
consid
grow
evid
pivot
role
rage
lung
diseas
asthma
allerg
airway
inflamm
acut
respiratori
distress
syndrom
ard
bronchopulmonari
solubl
rage
srage
repres
total
pool
solubl
form
rage
measur
extracellular
compart
eg
biolog
fluid
srage
lack
transmembran
domain
altern
splice
mechan
proteolyt
includ
extracellular
domain
mrage
thu
srage
act
decoy
prevent
activ
mrage
ligand
figur
sever
human
studi
argu
srage
marker
pulmonari
damag
process
adult
children
plasma
srage
associ
sever
prognosi
srage
measur
may
also
valuabl
assess
sever
asthma
howev
valu
measur
srage
acut
bronchiol
poorli
investig
design
studi
investig
whether
serum
srage
could
marker
sever
infant
acut
bronchiol
predictor
risk
develop
recurr
wheez
infant
age
year
admit
chu
acut
bronchiol
two
epidem
season
novemb
march
novemb
march
elig
case
bronchiol
diagnos
presenc
recent
histori
upper
respiratori
tract
infect
follow
onset
respiratori
distress
cough
tachypnea
retract
auscultatori
find
diffus
crackl
wheez
accord
intern
recommend
diagnosi
manag
acut
admiss
criteria
base
french
nation
pediatr
intens
care
unit
picu
need
case
sign
exhaust
listless
decreas
respiratori
effort
recurr
apnea
failur
maintain
adequ
oxygen
satur
despit
oxygen
infant
born
week
amenorrhea
infant
cystic
fibrosi
bronchopulmonari
dysplasia
suspect
primari
ciliari
dyskinesia
congenit
heart
diseas
immun
defici
acut
renal
failur
exclud
infant
age
year
attend
anesthesia
consult
ahead
plan
surgic
intervent
enrol
control
group
health
statu
evalu
complet
medic
clinic
questionnair
children
previou
histori
pulmonari
diseas
histori
wheez
cardiopulmonari
diseas
chronic
pulmonari
diseas
prematur
infecti
process
exclud
case
control
enrol
provid
parent
oral
written
inform
collect
written
consent
clinic
sever
assess
inclus
use
wainwright
clinic
score
base
respiratori
effort
oxygen
satur
respiratori
rate
score
defin
three
stage
sever
bronchiol
moder
data
collect
includ
person
medic
histori
perinat
atop
histori
immedi
complic
relat
acut
bronchiol
bacteri
superinfect
pneumothorax
atelectasi
use
oral
inhal
corticosteroid
immedi
morbid
mortal
assess
use
data
collect
hospit
length
hospit
stay
use
durat
enter
nutrit
parenter
rehydr
need
oxygen
therapi
respiratori
support
continu
posit
airway
pressur
cpap
posit
airway
pressur
bipap
invas
mechan
ventil
incid
superinfect
diagnos
biolog
radiolog
radiograph
featur
ventil
disord
ga
effus
bronchospasm
use
inhal
corticosteroid
death
famili
day
year
inclus
collect
data
recurr
wheez
bronchiol
asthma
wheez
without
consult
use
respiratori
treatment
oral
corticosteroid
respiratori
physiotherapi
hospit
admiss
respiratori
reason
diagnosi
recurr
wheez
alreadi
establish
anoth
pediatrician
base
occurr
third
bronchiol
episod
prescript
treatment
respiratori
symptom
admiss
hospit
blood
sampl
ml
sampl
venipunctur
tube
lithium
heparin
urin
ml
sampl
z
tube
without
addit
collect
pocket
compress
layer
blood
urin
sampl
immedi
centrifug
rpm
min
supernat
kept
frozen
analysi
srage
level
measur
duplic
use
elisa
kit
rage
quantikin
r
system
minneapoli
mn
limit
detect
pgml
personnel
respons
perform
srage
assay
knowledg
clinic
set
nasopharyng
swab
sampl
collect
aspir
nasal
secret
viral
analysi
carri
use
enzymat
immunoassay
chromatographi
rsv
antigen
detect
molecular
biolog
method
includ
revers
chain
reaction
rsv
rhinoviru
infant
admit
gener
pediatr
unit
multiplex
pcr
panel
adenoviru
coronaviru
metapneumoviru
enterovirusrhinoviru
influenza
b
parainfluenza
viru
rsv
bordetella
pertussi
chlamydia
pneumonia
mycoplasma
pneumonia
infant
admit
intens
care
unit
rhinoviru
strain
genotyp
chest
perform
respiratori
complic
andor
recurr
wheez
suspect
statist
analys
perform
use
stata
statacorp
colleg
station
tx
consid
statist
signific
data
express
frequenc
percentag
qualit
variabl
mean
standard
deviat
median
interquartil
interv
quantit
variabl
analysi
perform
use
test
fisher
exact
test
applic
qualit
variabl
student
test
mann
whitney
test
data
test
confirm
normal
quantit
variabl
sever
analysi
carri
use
quantit
analys
quantit
data
test
follow
trend
test
mean
test
fisher
exact
test
applic
qualit
data
follow
trend
test
srage
valu
analyz
use
mann
whitney
test
two
group
three
group
test
take
account
data
qualit
criteria
use
spearman
correl
coeffici
quantit
criteria
srage
valu
analyz
linear
regress
model
correct
clinic
relev
criteria
found
signific
univari
analysi
case
includ
mainli
young
infant
median
age
month
first
n
mild
n
episod
acut
bronchiol
case
moder
episod
present
sever
acut
bronchiol
accord
wainwright
score
viral
analysi
perform
infant
neg
nine
epidem
season
domin
rsv
n
rhinovirus
n
eighteen
viral
identifi
due
rsv
rhinoviru
median
hospit
stay
day
significantli
associ
wainwright
score
median
stay
day
bronchiol
day
moder
bronchiol
day
sever
bronchiol
p
infant
admit
intens
care
unit
includ
eight
case
admit
apnea
tabl
none
develop
ard
percent
case
famili
histori
atop
diseas
famili
histori
asthma
fifteen
percent
case
person
histori
atop
diseas
eczema
cow
milk
protein
allergi
recurr
wheez
studi
inclus
three
case
enrol
third
episod
one
case
includ
enrol
fourth
episod
bronchial
crackl
found
children
eight
percent
treat
inhal
corticosteroid
one
year
inclus
parent
case
respond
phone
survey
infant
develop
recurr
wheez
control
includ
median
age
month
p
case
boy
gender
differ
case
control
popul
statist
signific
p
differ
case
control
group
birth
term
p
weight
p
mean
serum
srage
sd
pgml
infant
acut
bronchiol
mean
serum
srage
correl
neg
age
r
p
highest
rate
found
among
younger
infant
tabl
correl
confirm
multivari
analysi
p
mean
serum
srage
sd
pgml
control
statist
signific
correl
age
r
p
tabl
serum
srage
level
significantli
higher
control
infant
acut
bronchiol
p
even
multivari
adjust
includ
age
covari
p
figur
multivari
analysi
show
lower
attrit
rate
point
case
addit
month
life
lower
attrit
rate
point
srage
level
differ
accord
causal
viru
srage
undetect
urin
sampl
signific
correl
serum
srage
clinic
sever
acut
bronchiol
hospit
admiss
accord
wainwright
score
figur
mean
serum
srage
level
sd
sd
sd
pgml
infant
moder
sever
acut
bronchiol
respect
p
serum
srage
correl
immedi
morbid
total
hospit
stay
r
p
type
hospit
unit
p
need
respiratori
support
p
durat
r
p
patient
complic
bacteri
superinfect
p
atelectasi
p
similar
srage
level
presenc
famili
histori
atop
diseas
impact
srage
level
asthma
p
food
allergi
p
allerg
rhiniti
p
eczema
p
serum
srage
associ
bronchial
crackl
p
use
inhal
corticosteroid
hospit
p
srage
level
correl
recurr
wheez
one
year
mean
serum
srage
sd
pgml
acut
episod
patient
develop
recurr
wheez
sd
pgml
develop
recurr
wheez
year
p
main
object
studi
investig
associ
serum
srage
sever
acut
bronchiol
hospit
infant
studi
enrol
infant
age
make
largest
cohort
patient
acut
bronchiol
publish
date
correl
found
serum
srage
sever
bronchiol
evalu
valid
intern
clinic
sever
score
inclus
note
ard
report
cohort
srage
level
seem
like
link
presenc
absenc
viral
episod
serum
srage
level
significantli
lower
infant
acut
bronchiol
control
regardless
natur
causal
viru
lack
correl
sever
acut
bronchiol
surpris
presenc
low
rate
acut
context
lead
us
imagin
lower
rate
among
sever
case
howev
result
show
correl
sever
acut
bronchiol
evalu
wainwright
score
could
also
surpris
addit
correl
srage
rate
sever
evalu
morbid
data
total
hospit
stay
type
hospit
unit
need
respiratori
support
respiratori
support
durat
morbid
data
probabl
even
reliabl
wainwright
score
sinc
evalu
inclus
case
low
number
sever
case
could
bia
studi
seem
true
accord
distribut
popul
establish
wainwright
score
howev
observ
sever
hospit
data
case
admit
intens
care
unit
repres
real
sever
case
acut
bronchiol
explain
low
serum
srage
level
acut
bronchiol
two
physiopatholog
hypothes
made
suppos
high
srage
level
could
exert
benefici
effect
block
axi
srage
consid
blocker
inflammatori
cascad
could
consum
bind
rage
ligand
order
control
inflamm
gener
viral
aggress
could
partli
explain
lower
srage
level
bronchiol
group
control
group
hand
may
hypothes
constitut
lower
srage
level
predispos
acut
bronchiol
sever
episod
result
first
observ
studi
must
confirm
larger
multicentr
popul
conclud
physiopatholog
model
cohort
studi
birth
measur
srage
kinet
could
arbitr
predispos
role
consequ
lower
srage
level
acut
bronchiol
regardless
relationship
srage
sever
acut
bronchiol
interpret
without
consider
age
inde
singular
featur
srage
level
infanc
broad
variabl
age
due
pulmonari
matur
alveolar
process
last
srage
level
decreas
progress
bronchoalveolar
fluid
balf
serum
week
amenorrhea
birth
birth
find
confirm
well
describ
figur
unfortun
obtain
data
control
infant
one
month
old
studi
may
underpow
detect
signific
neg
correl
serum
srage
age
control
major
variat
factor
srage
level
could
explain
discrep
studi
result
et
studi
show
pattern
opposit
higher
serum
srage
level
sever
acut
bronchiol
control
differ
pattern
seem
like
due
factor
et
al
control
older
target
popul
acut
bronchiol
averag
age
year
month
year
could
skew
comparison
group
physiolog
srage
level
higher
first
month
control
sampl
seem
precis
even
though
control
age
one
month
knowledg
studi
first
includ
healthi
control
year
age
data
avail
srage
level
target
popul
compar
fact
age
doubl
factor
bia
studi
sinc
acut
bronchiol
sever
youngest
case
adjust
age
thu
necessari
result
confirm
lower
rate
context
acut
bronchiol
even
adjust
age
occurr
acut
bronchiol
lower
srage
level
point
addit
month
life
lower
srage
level
point
srage
level
correl
recurr
wheez
year
follow
episod
acut
bronchiol
cohort
sever
studi
found
lower
serum
srage
level
children
asthma
healthi
children
especi
asthma
uncontrol
recent
studi
found
serum
srage
increas
inhal
taken
togeth
data
strongli
suggest
srage
level
lower
acut
viral
infect
chronic
asthma
bronchial
inflamm
potenti
deficit
srage
inflammatori
state
would
argu
therapi
applic
mous
studi
modul
rage
inhibit
elimin
express
protein
use
monoclon
antibodi
exogen
recombin
srage
improv
sever
featur
lung
injuri
model
ard
rsv
rsv
main
causal
viru
acut
bronchiol
especi
sever
given
neurogen
inflamm
caus
rsv
induc
bronchial
srage
administr
could
promis
candid
therapeut
target
futur
studi
aim
test
idea
studi
found
serum
srage
level
lower
infant
acut
bronchiol
without
acut
bronchiol
whatev
age
final
studi
show
differ
srage
level
accord
acut
bronchiol
sever
even
adjust
age
studi
age
major
confound
factor
acut
bronchiol
sever
sever
youngest
srage
physiolog
level
higher
rate
found
youngest
age
adjust
srage
rate
seem
relat
presenc
absenc
acut
bronchiol
rather
sever
long
term
srage
level
correl
risk
recurr
wheez
year
none
